Inventor · disambiguated record
Kevin R. Holme
Also filed as: HOLME KEVIN · HOLME KEVIN R · HOLME KEVIN ROSS
17 granted patents·4 pending applications·698 citations·filing 1992–2020
95Inventor score
Top patents by PatentIndex Score
21 records- 0195US5892112AProcess for preparing synthetic matrix metalloprotease inhibitorsGLYCOMED INC·Filed 1994·Granted Apr 6, 1999·177 cites·14 claims
- 0292US6534503B1Melanocortin receptor-3 ligands to treat sexual dysfunctionLION BIOSCIENCE AG·Filed 2000·Granted Mar 18, 2003·75 cites·71 claims
- 0389US6768024B1Triamine derivative melanocortin receptor ligands and methods of using sameLION BIOSCIENCE AG·Filed 2000·Granted Jul 27, 2004·28 cites·19 claims
- 0488US10774069B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2017·Granted Sep 15, 2020·2 cites·9 claims
- 0587US5808021AMethod for controlling O-desulfation of heparinGLYCOMED INC·Filed 1997·Granted Sep 15, 1998·79 cites·4 claims
- 0685US5795875ATherapeutic methods of using O-desulfated heparin derivativesGLYCOMED INC·Filed 1997·Granted Aug 18, 1998·65 cites·16 claims
- 0784US5654282ASelectin binding glycopeptidesGLYCOMED INC·Filed 1995·Granted Aug 5, 1997·58 cites·19 claims
- 0881US5296471AMethod for controlling o-desulfation of heparin and compositions produced therebyGLYCOMED INC·Filed 1992·Granted Mar 22, 1994·61 cites·8 claims
- 0978US5773438ASynthetic matrix metalloprotease inhibitors and use thereofGLYCOMED INC·Filed 1994·Granted Jun 30, 1998·36 cites·23 claims
- 1074US5696100AMethod for controlling O-desulfation of heparin and compositions produced therebyGLYCOMED INC·Filed 1995·Granted Dec 9, 1997·39 cites·12 claims
- 1171US5583121ANon-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromesUNIV MICHIGAN STATE·Filed 1994·Granted Dec 10, 1996·27 cites·19 claims
- 1264US6127347ANon-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromesUNIV MICHIGAN·Filed 1995·Granted Oct 3, 2000·22 cites·24 claims
- 1363US5874411AOligosaccharide glycosides having mammalian immunosuppresive and tolerogenic propertiesGLYCOMED INC·Filed 1996·Granted Feb 23, 1999·22 cites·11 claims
- 1460US11459309B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2020·Granted Oct 4, 2022·0 cites·5 claims
- 1557US9572785B2DP2 antagonist and uses thereofBRICKELL BIOTECH INC·Filed 2014·Granted Feb 21, 2017·0 cites·13 claims
- 1650US8815917B2DP2 antagonist and uses thereofBRITTAIN JASON EDWARD·Filed 2010·Granted Aug 26, 2014·0 cites·5 claims
- 1750US5508387ASelectin binding glycopeptidesGLYCOMED INC·Filed 1993·Granted Apr 16, 1996·7 cites·8 claims
- 1841US2003082625A1Method for the pretreatment of a surface for the reduction of non-specific binding by chemical entitiesFiled 2001·Application pending·0 cites
- 1938US2004009536A1System and method for predicting adme/tox characteristics of a compoundFiled 2001·Application pending·0 cites
- 2037US2004039530A1Pharmacokinetic tool and method for predicting metabolism of a compound in a mammalFiled 2001·Application pending·0 cites
- 2137US2004180322A1Regional intestinal permeability modelFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →